Stay updated on Pembrolizumab & Enobosarm in AR+ Metastatic TNBC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Enobosarm in AR+ Metastatic TNBC Clinical Trial page.

Latest updates to the Pembrolizumab & Enobosarm in AR+ Metastatic TNBC Clinical Trial page
- Check2 days agoChange DetectedThe site footer revision identifier changed from v3.7.0 to v3.7.1. The study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page now displays a 403 Forbidden state with a minimal header and Home button, and a large portion of the previous study-content sections has been removed, resulting in an error-page display rather than the full study details.SummaryDifference19%

- Check45 days agoChange DetectedThe study record page shows a version bump from v3.6.5 to v3.6.6, indicating a minor backend update rather than changes to study content.SummaryDifference0.1%

- Check66 days agoChange DetectedThe page now shows Revision: v3.6.5, replacing the previous Revision: v3.6.4. This reflects a small platform update applied to the page.SummaryDifference0.1%

- Check81 days agoChange DetectedPage revision updated from v3.6.3 to v3.6.4, signaling a new release of the page's UI/markup. No changes to the study details or descriptions are indicated.SummaryDifference0.1%

- Check102 days agoChange DetectedThe page's revision tag was updated to v3.6.3, replacing the previous v3.6.2.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab & Enobosarm in AR+ Metastatic TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Enobosarm in AR+ Metastatic TNBC Clinical Trial page.